Biotech

Biotechnology, gene editing, biopharma platforms, and clinical pipelines.

  • 9 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Biotech


thehindubusinessline.com > brandhub > pr-release > praj-and-gevo-enter-development-commercialization-agreement-for-bio-iba-in-india > article71471460.ece

Praj and Gevo Enter Development & Commercialization Agreement for Bio-IBA in India

42+ min ago   (185+ words) Englewood, Colorado, United States & Pune, Maharashtra, India – Business Wire India Praj Industries (PRAJIND | 522205) and Gevo Inc. (NASDAQ: Gevo) today announced the signing of a Development & Commercialization Agreement for Bio-Isobutanol (Bio-IBA) technology in India, reinforcing their long-standing association to advance sustainable…...


statnews.com > 09/16/2026 > biotech-news-sen-warren-demands-to-see-trump-drug-pricing-contracts

Sen. Warren demands to see Trump drug-pricing pharma contracts, accuses RFK Jr. of hiding them

36+ min ago   (116+ words) By Elaine Chen and Chelsea Cirruzzo Good morning. We’ve got a D.C.-heavy newsletter for you today. The FDA is opening applications for a pilot program designed to speed up the timeline for drugmakers to enter the clinic. Elaine’s stories explore…...


wsau.com > 09/16/2026 > novo-partners-with-anthropic-to-speed-up-drug-development-with-claude

Novo partners with Anthropic to speed up drug development with Claude

54+ min ago   (202+ words) Sept 16 (Reuters) – Novo Nordisk has partnered with Anthropic to use the AI giant’s Claude models to speed up ​discovery and development of new ‌medicines, the companies said on Wednesday. • The Danish drugmaker will initially test Anthropic models and Claude Science…...


freedom959.net > 09/16/2026 > sling-therapeutics-raises-123-million-to-advance-thyroid-eye-disease-drug

Sling Therapeutics raises $123 million to advance thyroid eye disease drug

3+ hour, 5+ min ago   (264+ words) By Kunal Das and Siddhi Mahatole Sept 16 (Reuters) – Drug developer Sling Therapeutics said on Wednesday it had raised $123 million to advance a late-stage trial ​of its experimental oral drug to treat thyroid ‌eye disease. The disease causes inflammation and swelling…...


miragenews.com > durham-spinout-lands-1-3m-for-drug-discovery-1745261

Durham Spinout Lands??1.3M for Drug Discovery Boost

3+ hour, 34+ min ago   (355+ words) Magnitude Biosciences, a Durham University spinout, has secured £1.3 million in investment to grow its approach to drug discovery and expand work with pharmaceutical and biotechnology companies. The new funding round was led by Northstar Ventures, with investment from the North…...


news-medical.net-medical.net

ACROBiosystems deepens its France presence with a dedicated hub at The HIVE Innovation Center, embedding into the Campus Grand Parc ecosystem

3+ hour, 37+ min ago   (191+ words) Kadans Science Partner is pleased to welcome ACROBiosystems to The HIVE Innovation Center, its laboratory and office building dedicated to the life sciences, situated on the Campus Grand Parc in Villejuif. ACROBiosystems’ arrival at The HIVE takes the form of…...


distilledpost.com > post > durham-spinout-magnitude-biosciences-raises-ps1-3m-to-expand-drug-discovery-platform

Durham Spinout Magnitude Biosciences Raises £1.3m to Expand Drug Discovery Platform

3+ hour, 38+ min ago   (357+ words) Magnitude Biosciences, a life sciences company spun out of Durham University, has raised £1.3 million to scale its drug discovery platform and expand its work with pharmaceutical companies. The company has developed VivoScan, a high throughput screening platform that uses C....


bebeez.eu > 09/16/2026 > brainomix-selected-for-prestigious-future-fifty-scale-up-programme

Brainomix Selected for Prestigious Future Fifty Scale-Up Programme

3+ hour, 58+ min ago   (259+ words) OXFORD, England and CHICAGO, Sept. 16, 2026 /PRNewswire/ — Brainomix, a global leader in AI-powered medical imaging, today announced that it has been selected to join Future Fifty, the UK’s most prestigious scale-up programme, recognizing the company as one of the country’s most…...


modernhealthcare.com > medical-devices > mh-medtech-mergers-acquisitions-q2-2026-pmcf

Medtech M&A picks up steam as economic uncertainty eases

4+ hour, 10+ min ago   (41+ words) Modern Healthcare Medtech M&A picks up steam as economic uncertainty eases CMS will add clinical tracks for conditions like heart failure and substance use disorders to the tech-enabled care model....